Skip to main content

Table 4 Effect of low and high doses of metal nanocomposite on cacium (Ca), phosphorus (Ph), malondialdehyde (MDA), reduced glutathione (GSH), uric acid and creatinine (Mean ± SE) n = 5

From: The efficacy of metal nanocomposite (Fe3O4/CuO/ZnO) to ameliorate the toxic effects of ochratoxin in broilers

 

G

Ca (mg/dl)

Ph (mg/dl)

MDA (nmol/ml)

GSH (mg/dl)

Uric acid (mg/dl)

Creatinine (mg/dl)

After treatment

1

7.98 ± 0.14b

7.56 ± 0.15b

3.40 ± 0.09a

0.28 ± 0.01b

6.85 ± 0.19b

0.32 ± 0.01a

2

6.02 ± 0.12a

6.02 ± 0.11a

8.95 ± 0.27c

0.16 ± 0.00a

7.83 ± 0.23c

0.56 ± 0.02c

3

7.87 ± 0.10 b

7.34 ± 0.21b

4.77 ± 0.12a

0.35 ± 0.00d

6.02 ± 0.17a

0.28 ± 0.00ab

4

8.11 ± 0.14b

7.65 ± 0.18b

6.81 ± 0.25b

0.36 ± 0.01d

6.51 ± 0.10a

0.36 ± 0.01a

5

6.65 ± 0.09a

6.87 ± 0.12b

7.24 ± 0.24b

0.32 ± 0.00c

7.29 ± 0.12b

0.45 ± 0.01ab

6

7.43 ± 0.13b

7.37 ± 0.10b

6.59 ± 0.19b

0.36 ± 0.01d

7.64 ± 0.26b

0.50 ± 0.02a

At the end of the experiment

1

7.27 ± 0.31b

8.18 ± 0.30bc

4.20 ± 0.17a

0.31 ± 0.01b

7.00 ± 0.25b

0.37 ± 0.01ab

2

5.47 ± 0.12a

6.16 ± 0.15a

9.08 ± 0.31c

0.19 ± 0.00a

9.33 ± 0.31c

0.62 ± 0.02c

3

7.30 ± 0.10b

7.87 ± 0.19b

4.14 ± 0.13a

0.30 ± 0.01b

4.40 ± 0.12a

0.33 ± 0.01ab

4

7.43 ± 0.27b

8.38 ± 0.26bc

5.11 ± 0.21ab

0.35 ± 0.01c

5.63 ± 0.18a

0.43 ± 0.00a

5

6.50 ± 0.11b

7.90 ± 0.22b

6.54 ± 0.26b

0.29 ± 0.01b

6.17 ± 0.24b

0.33 ± 0.01ab

6

7.03 ± 0.24b

8.37 ± 0.28bc

5.53 ± 0.15b

0.35 ± 0.01c

6.73 ± 0.21b

0.53 ± 0.00a

  1. The various letters in the same column of the same period indicate statistically significant differences when (P < 0.05)
  2. G1 = OTA free control, G2 = OTA fed positive control, G3 = OTA free (low dose), G4 = OTA free (high dose), G5 = OTA treated (low dose), G6 = OTA treated (high dose)